Healio

FibroScan after endoscopy found undiagnosed NAFLD, NASH

PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, as data presented at the American ...
KUTV

Check Your Health: A simple non-invasive test can tell you if you have a fatty liver

KUTV — Fatty liver disease is a chronic liver disease and is a rapidly growing problem here in Utah. It’s important to catch this disease early with a simple, non-invasive test and then make the ...
Business Wire

Echosens and ChronWell Announce Exclusive Strategic Partnership Between FibroScan and LIVErHEALTHY to Improve Patient Outcomes and Cost Savings

WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...
The Grand Junction Daily Sentinel

FibroScan device simplifies local liver scans

Just a few years ago, Grand Junction gastroenterologist Dr. William Shields was administering a lot of biopsies to diagnose the level of scarring in a patient's liver. The process involves a needle ...
Morningstar

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...
Medscape

Comparison of ELF, FibroTest and FibroScan for the Non-invasive Assessment of Liver Fibrosis

Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin).
Business Wire

Sentrex Health Solutions, in Collaboration With the Fatty Liver Alliance and Advanced Liver Imaging to Host a Community Liver Health Event in Recognition of International NASH Day

The Quiet Epidemic Taking a Toll on Liver Health: Community event aims to raise awareness about Non-Alcoholic Fatty Liver Disease and the importance of liver health. LONDON, Ontario--(BUSINESS ...
Healio

Q&A: FAST score, other noninvasive tests help identify, stratify at-risk MASH patients

Please provide your email address to receive an email when new articles are posted on . Researchers recommended the FibroScan-AST score to target those at risk for MASH. The score should be used with ...
manilatimes

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development This is the first time the FDA is ...